###begin article-title 0
Asthma and genes encoding components of the vitamin D pathway
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Genetic variants at the vitamin D receptor (VDR) locus are associated with asthma and atopy. We hypothesized that polymorphisms in other genes of the vitamin D pathway are associated with asthma or atopy.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP27A1</italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP27B1</italic>
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1</italic>
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1</italic>
###xml 155 157 155 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD28</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL8</italic>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SKIIP</italic>
Eleven candidate genes were chosen for this study, five of which code for proteins in the vitamin D metabolism pathway (CYP27A1, CYP27B1, CYP2R1, CYP24A1, GC) and six that are known to be transcriptionally regulated by vitamin D (IL10, IL1RL1, CD28, CD86, IL8, SKIIP). For each gene, we selected a maximally informative set of common SNPs (tagSNPs) using the European-derived (CEU) HapMap dataset. A total of 87 SNPs were genotyped in a French-Canadian family sample ascertained through asthmatic probands (388 nuclear families, 1064 individuals) and evaluated using the Family Based Association Test (FBAT) program. We then sought to replicate the positive findings in four independent samples: two from Western Canada, one from Australia and one from the USA (CAMP).
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1</italic>
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1</italic>
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 456 464 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 664 668 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
A number of SNPs in the IL10, CYP24A1, CYP2R1, IL1RL1 and CD86 genes were modestly associated with asthma and atopy (p < 0.05). Two-gene models testing for both main effects and the interaction were then performed using conditional logistic regression. Two-gene models implicating functional variants in the IL10 and VDR genes as well as in the IL10 and IL1RL1 genes were associated with asthma (p < 0.0002). In the replicate samples, SNPs in the IL10 and CYP24A1 genes were again modestly associated with asthma and atopy (p < 0.05). However, the SNPs or the orientation of the risk alleles were different between populations. A two-gene model involving IL10 and VDR was replicated in CAMP, but not in the other populations.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
A number of genes involved in the vitamin D pathway demonstrate modest levels of association with asthma and atopy. Multilocus models testing genes in the same pathway are potentially more effective to evaluate the risk of asthma, but the effects are not uniform across populations.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
Asthma is a heterogeneous respiratory disease characterized by chronic inflammation of the airways associated with recurrent symptoms that range from mild to debilitating [1]. Asthma is in large part attributable to genetic factors [2]. However, identifying the causal genes has been a daunting task due to the inherent complexity of the disease as well as methodological issues related to finding genes of complex diseases [3]. The emerging picture from the literature suggests hundreds of genes are associated with asthma or asthma-related phenotypes [4,5]. Major efforts are currently underway to validate these genes in larger populations as well as to identify novel genes using new technology-driven approaches such as genome-wide single-nucleotide-polymorphism (SNP) association studies [6-8].
###end p 10
###begin p 11
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 778 779 774 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1026 1028 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
The innate and adaptive immune systems play an important role in the pathogenesis of asthma. Many genes involved in inflammation and immunoregulation pathways have been associated with asthma [3]. The immune system is complex in nature with multiple redundant and interfering pathways. Recently, the vitamin D pathway has emerged as a new pathway contributing to the outcome of immune responses [9-12]. The vitamin D pathway has long been recognized for its endocrine actions on bone and mineral homeostasis. However, growing knowledge has elucidated autocrine and paracrine roles for the vitamin D system with respect to cell growth, proliferation and differentiation as well as in immune regulation [13]. The biologically active form of vitamin D (1alpha,25-dihydroxyvitamin D3), also known as calcitriol, mediates its effect by binding to the nuclear vitamin D receptor (VDR). Upon activation, the VDR ligand/receptor complex alters the transcription rate of many genes involved in a wide spectrum of biological responses [14].
###end p 11
###begin p 12
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1021 1023 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1072 1076 1068 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
The hypothesis that the vitamin D pathway plays a role in autoimmune diseases such as asthma, originates from the identification of VDR in immunological relevant cells, including antigen-presenting cells and activated T lymphocytes [15,16]. How VDR affects immune cell populations, cytokine secretion, and production is not entirely known, but previous evidence suggests that VDR activation may cause a developmental shift of T helper (Th) cells toward type 2 [17,18]. The hypothesis that VDR plays a role in asthma was also reinforced by the resistance of VDR knock-out mice to experimentally induced asthma [19]. These mice fail to develop airway inflammation, eosinophilia, or airway hyperresponsiveness, despite high IgE concentration and elevated Th2 cytokines. Recently, a functional polymorphism (FokI, rs2228570) in the VDR gene was shown to have a functional impact on the immune system by interfering with the signaling of transcription factors important in immune-mediated diseases such as NF-kappaB and NFAT [20]. Taken together, these studies clearly support VDR as a possible candidate gene for asthma.
###end p 12
###begin p 13
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 971 975 971 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1363 1367 1363 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1429 1433 1429 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1534 1536 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1596 1600 1596 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1858 1862 1858 1862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
Two groups co-reported that genetic variants within the VDR gene were associated with asthma [21,22]. In a French-Canadian founder population, Poon et al. [21] demonstrated that six SNPs located between intron 2 and exon 9 spanning 28 kb of the VDR gene were associated with asthma. Linkage disequilibrium (LD) patterns within this population revealed the presence of two blocks (block 1 and 2) containing 3 and 4 common haplotypes, respectively. One haplotype within each block was overtransmitted to affected offspring. By sequencing the promoter, exons and surrounding regions, they excluded novel missense mutations that could explain the observed association. In a second study, Raby et al. [22] found significant associations between VDR variants and asthma in two independent studies. They first screened seven candidate genes that map to the centromeric region of chromosome 12 in the Childhood Asthma Management Program (CAMP) study. Only one SNP located in the VDR gene demonstrated evidence of association with asthma. Consistent with the French-Canadian population, two LD blocks were observed, each with three common haplotypes. The 3' haplotype block in the CAMP study was significantly associated with asthma. To exclude the possibility that neighboring genes cause the association, the authors genotyped 29 SNPs in a 330 kb region surrounding the VDR gene. None of these SNPs were associated with asthma, leaving VDR as the most likely causal gene. Their finding was then replicated in the Nurses' Health Study (NHS) [22]. In that study, four of the six genotyped SNPs within the VDR gene were associated with asthma. However, it should be noted that the direction of the association in NHS was opposite to the effects seen in CAMP, but similar to the findings in the French-Canadian population. Taken together, these data suggested that the VDR locus harbors variants that contribute to asthma, but the orientation of the risk allele is inconsistent across populations.
###end p 13
###begin p 14
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
Numerous metabolic pathways are likely to play a major role in complex diseases. It is necessary to study the components of these pathways to gain a more comprehensive genetic view of the susceptibility conferred by variants located in closely related genes [23,24]. Accordingly, we hypothesized that polymorphisms in other genes involved in the vitamin D system are associated with asthma or atopy.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Population
###end title 16
###begin p 17
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
###xml 1170 1172 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1266 1268 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1277 1278 1275 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Subjects were from the Saguenay_Lac-Saint-Jean (SLSJ) asthma study, which consists of French-Canadian families ascertained through asthmatic probands. Probands were included in the study if they fulfilled at least two of the following criteria: 1) a minimum of three clinic visits for acute asthma within one year; 2) two or more asthma-related hospital admissions within one year; or 3) steroid dependency, defined by either six month's use of oral, or one year's use of inhaled corticosteroids. A total of 1064 individuals from 388 nuclear families were included in the present analyses. Families were included in the study if at least one parent was available for phenotypic assessment, at least one parent was unaffected, and all four grandparents were of French-Canadian origin. Family members were considered asthmatics if both a self-reported history of asthma and a history of physician-diagnosed asthma were recorded, or by clinical evaluation following a methacholine provocation test. Skin-prick tests were performed for 26 inhalant allergens and subjects were considered atopic if they had at least one positive response (wheal diameter >/= 3 mm at 10 min) [25]. Spirometry, methacholine challenge and IgE measurements are described in detail elsewhere [21]. Table 1 presents the characteristics of the subjects. The SLSJ local ethics committee approved the study, and all subjects gave informed consent.
###end p 17
###begin p 18
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
Characteristics of the subjects in the Saguenay_Lac-Saint-Jean study.
###end p 18
###begin p 19
Values are means +/- SD for quantitative variables.
###end p 19
###begin p 20
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 48 50 48 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
FEV1, Forced expiratory volume in one second; PC20, Concentration of methacholine inducing a 20% fall in FEV1; PEFR, Peak expiratory flow rate (morning-evening variation).
###end p 20
###begin title 21
Replication samples
###end title 21
###begin p 22
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 3254 3256 3252 3254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 3257 3259 3255 3257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 568 575 <span type="species:ncbi:9606">infants</span>
###xml 595 602 <span type="species:ncbi:9606">infants</span>
###xml 777 785 <span type="species:ncbi:9606">children</span>
###xml 908 916 <span type="species:ncbi:9606">children</span>
###xml 1204 1212 <span type="species:ncbi:9606">Children</span>
###xml 1288 1296 <span type="species:ncbi:9606">children</span>
###xml 1362 1370 <span type="species:ncbi:9606">children</span>
###xml 1477 1485 <span type="species:ncbi:9606">children</span>
###xml 1533 1541 <span type="species:ncbi:9606">children</span>
###xml 1617 1625 <span type="species:ncbi:9606">children</span>
###xml 1658 1666 <span type="species:ncbi:9606">children</span>
###xml 1752 1760 <span type="species:ncbi:9606">children</span>
###xml 1933 1941 <span type="species:ncbi:9606">children</span>
###xml 2226 2234 <span type="species:ncbi:9606">children</span>
###xml 2327 2339 <span type="species:ncbi:9606">participants</span>
###xml 3215 3223 <span type="species:ncbi:9606">children</span>
###xml 3936 3948 <span type="species:ncbi:9606">participants</span>
Data from the Canadian Asthma Primary Prevention Study (CAPPS) study, the Study of Asthma Genes and the Environment (SAGE) birth cohort and the Busselton Health Study (BHS) were used to replicate the findings. The Childhood Asthma Management Program (CAMP) study was also used to replicate a specific gene-gene (VDR-IL10) interaction models. The CAPPS and SAGE studies have been described elsewhere [26]. Briefly, the CAPPS study was initiated in 1995 to assess the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants [27,28]. High-risk infants were identified before birth as having at least one first-degree relative with asthma or two first-degree relatives with other IgE-mediated allergic diseases. A total of 549 children and their parents forming 545 families were enrolled in the study during the second and third trimester of pregnancy. The children were followed since birth and were assessed by a pediatric allergist for the presence of asthma and allergies. Atopy was defined by skin-prick test. A total of 16 allergens were tested and the diagnosis was positive if at least one wheal >/= 3 mm than the negative control was observed. Children with 7 year follow-up data and DNA were included in the current study (380 children/families). The SAGE study is a population-based cohort of 16,320 children born in the province of Manitoba, Canada, between January 1, 1995 and December 31, 1995. Parents of these children were first survey by mail in 2002. A subset of children was then invited to join the study at age 8-10 years. This subset included children with parent-declared asthma and children without asthma. A total of 723 families were recruited into the study. All recruited children underwent clinical assessment of asthma by a pediatric allergist. Skin prick testing for 16 allergens was used to define atopy. In the two latter studies (SAGE and CAPPS), children affected with asthma/atopy and their parents were genotyped and analysed in trios. In contrast, the BHS was analysed using a case-control design. This study comprised a series of six cross-sectional health surveys that took place every three years from 1966 to 1981 in all adults and children residing in the Shire of Busselton, Western Australia and a follow-up study of all previous participants (residing within and outside this Shire) in 1994/1995. Busselton is a coastal town in the South West region of Western Australia with a population that is predominantly of European origin. In the present case-control study, all subjects (n = 1395, 751 controls and 644 cases) who attended both the 1981 and the 1994 survey and who had a diagnosis of asthma as well as available DNA were included. Subjects were considered to have asthma if they answered yes to the question "Has your doctor ever told you that you had asthma/bronchial asthma?" in a written questionnaire at either survey. Subjects were considered controls if they answered no at both surveys. Skin prick testing for 12 allergens was used to define atopy. Finally, CAMP is a multicentered North American clinical trial designed to investigate the long-term effects of inhaled anti-inflammatory medications in children with mild to moderate asthma [29,30]. A total of 1625 individual members of 428 non-Hispanic white nuclear families were included in the present analyses. This represents the subset non-Hispanic with CAMP families with available SNP genotype data at both the VDR and IL10 loci. The diagnosis of asthma was based on a methacholine provocation test and one or more of the following criteria for at least 6 months in the year before recruitment: 1) asthma symptoms at least two times per week, 2) at least two uses per week of an inhaled bronchodilator, and 3) daily asthma medication. A local ethics committee approved the protocol independently in each study. Written informed consent was obtained from all study participants.
###end p 22
###begin title 23
Gene selection
###end title 23
###begin p 24
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 687 691 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 693 699 693 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1</italic>
###xml 701 705 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD28</italic>
###xml 707 712 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 716 719 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL8</italic>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
Eleven candidate genes were chosen for this study. Figure 1 is a cartoon of the vitamin D pathway that illustrates the implication of each gene selected. Briefly, genes encoding key components of the vitamin D pathway were chosen, which include: enzymes responsible for the activation and inactivation vitamin D (CYP27A1, CYP27B1, CYP2R1 and CYP24A1) [31,32]; the vitamin D binding protein (GC) that binds to vitamin D and its plasma metabolites and transports them to target tissues; SKIIP, also known as NCoA62/SKIP, that serves as a coactivator a vitamin D-mediated transcription [33]; and five revevant genes for asthma that are known to be transcriptionally regulated by vitamin D (IL10, IL1RL1, CD28, CD86 and IL8) [14].
###end p 24
###begin p 25
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genes involved in the vitamin D pathway</bold>
###xml 50 52 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 288 290 284 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 291 292 287 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 295 303 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP27A1 </italic>
###xml 307 314 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1 </italic>
###xml 413 414 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 453 461 449 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP27B1 </italic>
###xml 542 544 534 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 545 547 537 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 742 744 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 806 808 794 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 809 811 797 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 923 926 911 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC </italic>
###xml 1010 1018 998 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 1067 1069 1051 1053 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 1070 1072 1054 1056 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 1333 1335 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
Genes involved in the vitamin D pathway. Vitamin D3 comes from the diet but is mostly produced in the skin by the photolytic cleavage of 7-dehydrocholesterol. From vitamin D3, two enzymatic activation steps are required to produce the biologically active form of vitamin D [1alpha,25-(OH)2 D3]. CYP27A1 and CYP2R1 genes encode enzymes with 25-hydroxylase activity that catalyze the C-25 hydroxylation of vitamin D3. A final activation enzyme encoded by CYP27B1 subsequently catalyzes the rate-limiting C-1 hydroxylation step in 1alpha,25-(OH)2 D3 synthesis. The later enzyme is tightly-regulated in the kidney by calcium homeostatic signals, but also strongly induced by immune inputs (e.g. TLR signaling) in many cells of the immune system [12] (not depicted). The active form of vitamin D, 1alpha,25-(OH)2 D3 (orange triangle), is then transport to vitamin D target cells by the vitamin D binding protein (encoded by the GC locus) or is metabolically inactivated by the 24-hydroxylase enzyme (encoded by the CYP24A1 locus). In vitamin D target cells, 1alpha,25-(OH)2 D3 translocates to the nucleus and binds to the vitamin D receptor (VDR). The ligand/receptor complex binds vitamin D response element (VDRE) located in the promoter region of target genes. The DNA-bound complex interacts with nuclear coregulators, such as SKIIP [33], and alters the rate of gene transcription. Five genes having a VDRE or/and being transcriptionally regulated by vitamin D stimulation are shown (blue square). Genes selected for genotyping in the SLSJ study are circled in blue.
###end p 25
###begin title 26
SNP selection
###end title 26
###begin p 27
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 518 520 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 622 624 622 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1055 1057 1055 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1354 1355 1354 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1444 1445 1444 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
SNPs were selected using the CEPH genotype dataset from phase 1 of the International HapMap project [34]. The genotype data were downloaded from the genomic region covering ten kilobases up- and downstream of each gene. A maximally informative set of SNPs was selected using a pairwise tagging algorithm described by Carlson et al. [35]. A Perl program, called ldSelect , was used to select the SNPs in each gene. Briefly, this program analyzes the pattern of LD between SNPs and forms bins of SNPs in LD based on an r2 threshold. The algorithm ensures that all pairwise LD values between SNPs in the same bin exceed the r2 threshold. Accordingly, any SNP in a bin can serve as a proxy (tagSNP) for all other SNPs in the same bin. Only one tagSNP needs to be typed per bin. At this level, nonsynonymous SNPs genotyped in the HapMap dataset were prioritized using the "-required" option. Similarly, some SNPs were prioritized based on the type of variation (A/T, C/T, etc) to meet the genotyping technology requirement. The minor allele frequency and the r2 thresholds were set at 0.05 and 0.8, respectively, using the "-freq" and "-r2" options. Known nonsynonymous SNPs or functional variants not genotyped in the HapMap dataset were also selected for genotyping. Selected SNPs and their characteristics are shown in additional file (see Additional file 1). The location of SNPs relative to the gene structure is illustrated in Additional file 2.
###end p 27
###begin title 28
Genotyping
###end title 28
###begin p 29
###xml 73 77 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174; </sup>
###xml 93 95 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 168 170 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 346 348 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 671 673 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 794 796 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 808 810 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
In the SLSJ study, a total of 87 SNPs were genotyped using the SNP stream(R) UHT technology [36]. Primers were designed using FastPCR version 3.8.78 for multiplex PCR [37]. Single base extension primers were designed using Autoprimer.com (Beckman Coulter). The protocol and reaction conditions were performed in accordance with the manufacturer [36]. SNPs were genotyped in different panels that were organized by grouping SNPs with the same type of variation (A/T, C/T, etc) and by respecting the 12-plex maximum capacity of the system. For the replication studies (CAPPS, SAGE and BHS), 52 SNPs located in five genes were genotyped using the Illumina GoldenGate assay [38] as part of a larger SNP genotyping panel . SNP genotypes in CAMP available from prior analyses were generated for VDR [22] and IL10 [39] using the MassARRAY platform (Sequenom, San Diego, CA) and SNaPShot (Applied Biosystems, Forrest City, CA), respectively, as previously described.
###end p 29
###begin title 30
Statistical analyses
###end title 30
###begin p 31
###xml 140 142 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 295 297 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1143 1145 1141 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1189 1191 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1269 1271 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
Mendelian inheritance incompatibilities were inspected using Pedmanager version 0.9 and Hardy-Weinberg equilibrium was evaluated using a chi2 test among parents. For the SLSJ, CAPPS and SAGE studies the Family Based Association Test (FBAT) program was used to test association with single SNPs [40]. All tests were performed with an additive model using the empirical variance-covariance estimator that adjusts for the correlation among sibling genotypes and for multiple nuclear families within a single pedigree. The FBAT test provides a Z-statistic with the corresponding p value. A positive Z-statistic is indicative of a high-risk allele and a negative Z-statistic is indicative of a protective allele. In the BHS, the single SNP associations were evaluated using the Cochran-Armitage test for trend with additive coding of alleles. Genes showing at least one SNP with a p < 0.05 in the SLSJ collection were considered for validation in the other populations. Our strategy to deal with multiple testing was to replicate the associations in independent populations instead of using an adjusted p value. LD values were evaluated using the r2 metrics and calculated with Haploview 3.32 [41]. Power calculations for the four study populations were recently described [42].
###end p 31
###begin p 32
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
Gene-gene interactions were evaluated for asthma and atopy using a multilocus analysis method following the framework described in Millstein et al. [23]. This strategy is based on likelihood-ratio tests that used a log-additive coding scheme, where genotypes aa, Aa, and AA are coded as 0, 1, and 2, respectively. Briefly, the analyses were performed in two stages. In stage one, single SNP tests of associations were evaluated by contrasting the null hypothesis of no association with the alternative hypothesis. The threshold for significance for stage one of the gene-gene interaction tests was then adjusted for multiple testing using the Bonferroni correction. In stage two, a full two-gene interaction model, including the two main effects and the interaction term, was tested against the reduced model that includes only the main effects that were declared significant in the first stage, if any. This strategy avoids retesting the same effects detected in stage one. While the framework of Millstein et al. [23] was described for a case-control dataset, it can easily be adapted to a case-parent design by following the case/pseudocontrol design described by Cordell et al. [43], where each case is matched with three pseudocontrols derived from the untransmitted parental alleles. Following this, conditional logistic regression is used to assess the significance of the main and interaction terms. Since transmission to multiple affected siblings cannot be assumed to be independent events, and since the families in our sample may contain more than one case, robust estimates for the variance and Wald tests were used instead of likelihood ratio tests for the SLSJ, CAPPS and SAGE studies. Considering the number of SNPs genotyped in genes involved in the vitamin D pathway, a total of 5003 two-gene interaction models were evaluated.
###end p 32
###begin p 33
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Post hoc </italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
Post hoc analyses were performed with the combined dataset (SLSJ, CAPPS, SAGE, and BHS). Tests of association were performed using the likelihood method implemented in UNPHASE v3.0.10 [44], which allow data from family studies and case-control individuals to be analyzed together.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
Results from the SLSJ population
###end title 35
###begin p 36
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC </italic>
###xml 328 336 328 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP27B1 </italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 833 841 833 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 984 985 984 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
Additional file 1 presents the 87 genotyped SNPs and their characteristics in the SLSJ study. Two SNPs failed the assay design including one in the CD86 gene (rs1915087) and another in the GC gene (rs1491711). Both of these SNPs are singletons and are not tagging other SNPs in the genes. A third SNP (rs8176353) located in the CYP27B1 gene was monomorphic. Additional file 1 also showed the minor allele frequencies for a reference population (CEPH from HapMap) and for the SLSJ study. In most cases, the minor allele frequencies were very similar between the two populations with a mean difference of 2% and the largest difference was 16% for SNP rs4308217 located in the CD86 gene. After Bonferroni correction, only one SNP was out of Hardy-Weinberg equilibrium (see Additional file 1). This SNP (rs4809960) is a singleton in the CYP24A1 gene and was removed from further analyses. Accordingly, a total of 83 SNPs were tested for association with asthma and atopy. Additional file 2 shows the exon-intron structure of each gene and the location of genotyped SNPs.
###end p 36
###begin p 37
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S4">4</xref>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 810 812 810 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 871 872 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 1261 1269 1261 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 1451 1453 1451 1453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1612 1614 1612 1614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1627 1628 1627 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 1658 1665 1658 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 1762 1764 1762 1764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1838 1839 1838 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 1915 1920 1915 1920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 2095 2102 2095 2102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1 </italic>
###xml 2205 2206 2205 2206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1108 1116 <span type="species:ncbi:9606">patients</span>
The overall distribution of single marker FBAT association tests shows a greater number of small p values for asthma compared to what was expected by chance (see Additional file 3). Results for genes with at least one significant p value for asthma and atopy are illustrated in Figure 2 (results for all genes are illustrated in Additional file 2). The details of these tests are shown in Table 2 for SNPs having at least one p value < 0.1 for asthma or atopy (FBAT results for all SNPs can be found in Additional file 4). Five SNPs in the IL10 gene, three located in the promoter (rs1800872, rs1800871, rs1800896), one in intron 1 (rs3024490), and the other located in the 3' region (rs4844553) were significantly associated with asthma. Three of them (rs1800871, rs1800872, and rs3024490) were in tight LD (r2 > 0.97), while the others were in low to modest LD (Figure 3). Haplotype analysis for the three tightly linked SNPs revealed the presence of only two haplotypes with an allele frequency above 1% in the SLSJ population. The TAA haplotype had a frequency of 0.268 and was overtransmitted to asthma patients (p = 0.024), while the CCC haplotype had a frequency of 0.726 and was undertransmitted (p = 0.013). Four out of the eight genotyped SNPs in the CYP24A1 gene were also modestly associated with asthma or atopy (range of p values = 0.051 to 0.015). The two intronic SNPs associated with atopy (rs912505 and rs927650) were in modest LD (r2 = 0.36) and the two SNPs associated with asthma (rs2248359 and rs8124792) located in the promoter and the 3' region of the gene were in complete equilibrium (r2 = 0) (Figure 3). Three intronic SNPs in the IL1RL1 gene were also associated with asthma. Two of them (rs1420089 and rs1861245) were in modest LD (r2 = 0.28) and the third one (rs1946131) showed no LD with the other (Figure 3). Also worth mentioning is a SNP (rs2715267) in the promoter region of the CD86 gene that was significantly associated with atopy (p = 0.004). A trend for this SNP was also observed for asthma (p = 0.069). Finally, one SNP (rs11023374) in intron 2 of the CYP2R1 gene was associated with asthma (p = 0.017). LD plots for all genes are illustrated in Additional file 5.
###end p 37
###begin p 38
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
Single SNP association results for asthma and atopy in the Saguenay_Lac-Saint-Jean study.
###end p 38
###begin p 39
*Number of informative families to conduct the test.
###end p 39
###begin p 40
P values < 0.05 are shown in bold.
###end p 40
###begin p 41
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genetic association of SNPs in the vitamin D pathway genes with asthma and atopy in the SLSJ study</bold>
###xml 739 742 739 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10 </sub>
###xml 663 668 <span type="species:ncbi:9606">Human</span>
Genetic association of SNPs in the vitamin D pathway genes with asthma and atopy in the SLSJ study. Only genes with a least one significant p value (p < 0.05) are illustrated. Each subfigure presents the result of one gene. The top line indicates the gene name and symbol. The upper part of each subfigure shows the exon-intron structure of the gene and the localization of the genotyped SNPs. The coding exons are shown in black and the untranslated regions are shown in grey. The lower part of each subfigure illustrates the association results for asthma (solid circles) and atopy (open circles). The x-axis shows the localization of the gene and SNPs on NCBI Human Genome build 35. The y-axis shows the FBAT empirical p values on a log10 scale. The lower and upper dashed lines represent p value thresholds of 0.05 and 0.001, respectively. The upper and lower parts of each subfigure are shown on the same scale.
###end p 41
###begin p 42
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Linkage disequilibrium (LD) plots surrounding five genes involved in the vitamin D pathway in the SLSJ study</bold>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 351 353 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 422 424 422 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 474 476 474 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 487 489 487 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
Linkage disequilibrium (LD) plots surrounding five genes involved in the vitamin D pathway in the SLSJ study. The LD plots were generated by Haploview 3.32 [41]. Gene symbols are indicated at the top of each graph. The top horizontal bar illustrates the location of SNPs on a physical scale. The color of squares illustrates the strength of pairwise r2 values on a black and white scale where black indicates perfect LD (r2 = 1.00) and white indicates perfect equilibrium (r2 = 0). The r2 LD value is also indicated within each square. Blocks are defined using the Gabriel et al [71] definition. Failed and monomorphic SNPs as well as SNPs not in Hardy-Weinberg equilibrium are not illustrated.
###end p 42
###begin p 43
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 584 589 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S6">6</xref>
Interaction among functionally related genes may not be surprising. Hence, all possible two-gene interactions were tested for asthma in the SLSJ study for the 11 genes under study plus the VDR gene (Figure 4). Two concentrated spots of significant two-gene models for asthma are observed in this figure. The one at the bottom represents two-gene models involving SNPs in the IL10 and VDR genes. The second spot located in the center of Figure 4 represents two-gene models involving SNPs in the IL10 and IL1RL1 genes. Multiple two-gene models were also significant between SNPs in the IL10 and CD86 genes. Additional file 6 shows the two-gene models for atopy in the SLSJ study. Overall, gene-gene interactions were modest for atopy.
###end p 43
###begin p 44
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Two-gene model analyses on asthma in the SLSJ study for genes involved in the vitamin D pathway</bold>
###xml 901 912 <span type="species:ncbi:7116">large white</span>
Two-gene model analyses on asthma in the SLSJ study for genes involved in the vitamin D pathway. The plot illustrates the p values for single SNP association and all possible two-SNP combinations. Each line represents a SNP listed at the left of the figure. Each column represents a SNP listed in the same order but from left to right. The white horizontal and vertical lines break up the figure by genes. Gene names are indicated at the right of the figure. P values are illustrated using the following color scheme: grey, p > 0.05; blue, 0.05 > p > 0.01; yellow, 0.01 > p > 0.001; orange, 0.001 > p > 0.0001, red, 0.0001 > p > 0.00001. The squares forming the diagonal (upper-left to lower-right) depict p values for single SNP association based on a Wald test (see materials and methods). Two-gene models for SNPs located in the same gene were not assessed and were not coloured, which created the large white square patterns along the diagonal. Illustrated above the diagonal are p values for the interaction term only, which are the results of Wald tests contrasting the full model (two main effects and the interaction) to the reduced model (two main effects only). Illustrated below the diagonal are p values testing the full model (two main effects and the interaction) against a reduced model that is conditional on single SNPs declared significant when taken individually, if any (see materials and methods). White squares illustrate tests for which the model failed to converge.
###end p 44
###begin p 45
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 228 233 228 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5a, b</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5c</xref>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5a</xref>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 650 655 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 711 715 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5b</xref>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5a</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5b</xref>
###xml 996 1001 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1025 1028 1025 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5c</xref>
###xml 1198 1203 1198 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1319 1323 1319 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5d</xref>
###xml 1415 1420 1415 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1463 1470 1463 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 1500 1505 1500 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1614 1621 1614 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 1634 1636 1634 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5e</xref>
###xml 1710 1715 1710 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1719 1724 1719 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 1803 1808 1803 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 1836 1841 1836 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
To understand the impact of these two-gene models on the risk of asthma, the genotype by genotype odds ratio matrix was calculated and some representative and most significant two-gene models are illustrated in Figure 5. Figure 5a, b and 5c show two-gene models between SNPs in the IL10 and VDR genes. Figure 5a shows that the risk of having asthma is similar for carriers of two rare IL10 alleles irrespective of the VDR genotypes. However, the risk increases with the increasing number of common IL10 alleles for individuals who are homozygous for the common VDR allele. In contrast, the risk tends to decrease with the increasing number of common IL10 alleles for individuals who are homozygous for the rare VDR allele. Figure 5b shows that the risk of asthma increases with the number of rare IL10 alleles, but the effect is greater with an increasing number of common alleles at the VDR locus. Figure 5a and 5b show representative interactions between SNPs located in the promoter region of IL10 and the 3'UTR region of VDR. However, more complex interactions between these two genes were observed between SNPs located in the 3'UTR region of both genes. Figure 5c shows that the effect of the IL10 rare allele goes in the opposite directions depending on whether subjects are homozygous for the common or the rare VDR alleles. Figure 5d shows a representative interaction between promoter polymorphisms in the IL10 gene and nonsynonymous SNPs located in the IL1RL1 gene. In this model, the rare IL10 alleles increase the risk, but the magnitude of the effect is greater with the number of rare alleles at the IL1RL1 gene. Figure 5e shows a representative interaction between promoter polymorphisms in the IL10 and CD86 genes. In this model, the risk of asthma is similar for carriers of two common CD86 alleles irrespective of the IL10 genotypes, however, the risk increases additively with the number of rare alleles in the two genes.
###end p 45
###begin p 46
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Combined genotypic effects of selected two-gene models on asthma in the SLSJ study</bold>
###xml 523 525 523 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
Combined genotypic effects of selected two-gene models on asthma in the SLSJ study. Each subfigure illustrates the risk of asthma according to two SNPs located in different genes. The genes and SNPs named are indicated above each subfigure representing SNP 1 and SNP 2, respectively. With two bi-allelic SNPs (3 genotypes per SNP), a 3 by 3 odds ratio matrix is calculated and visually represented. All risks are evaluated relative to homozygotes for the common allele at both SNPs. The y-axis shows the odds ratio on a log2 scale, which makes the odds ratio above and below 1 on the same visual scale. The x-axis indicates the genotypes for SNP number 1. By drawing a line that joins the dots representing the genotypes for SNP number 2, the genotypic effect of SNP number 1 can be observed on different genotypic backgrounds of SNP number 2. The first three p values come from a model testing the main effect of both SNPs and the interaction term. The Wald test p value is the result of the full two-gene model tested against a reduced model (see materials and methods).
###end p 46
###begin title 47
Replication samples
###end title 47
###begin p 48
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1</italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1</italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86</italic>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1 </italic>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S7">7</xref>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 1427 1432 1427 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1602 1607 1602 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1722 1727 1722 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
For all the single SNP associations observed in the SLSJ population, the statistical significance was modest and did not survive multiple correction procedures. Accordingly, an effort was made to replicate these findings in three additional studies. A comprehensive set of tagging SNPs in the IL10, CYP24A1, IL1RL1, CD86, and CYP2R1 genes plus the significant (p < 0.05) SNPs in the SLSJ study were genotyped in the CAPPS, SAGE and BHS studies. Table 3 shows SNPs with at least one p value < 0.05 for asthma or atopy in the three studies as well as SNPs with p value < 0.05 in the SLSJ study. Complete results for the replicate samples can be found in Additional file 7. For IL10, none of the SNPs associated with asthma in the SLSJ study were significant in the other studies except the promoter polymorphism rs1800896, with a marginal p value of 0.022 in CAPPS. However, the C allele that was protective in the SLSJ study was the risk allele in the CAPPS study. The direction of the risk allele in the SAGE study was similar to the one observed in the SLSJ, but the effect was not significant. Similar flip-flop phenomena were observed between the SAGE and CAPPS studies for SNPs that were not significant in the SLSJ study. Two SNPs in tight LD, rs3024498 located in the 3'UTR and rs3024492 located in intron 3, showed p values > 0.01 in both replicate samples, but the orientation of the risk allele was reversed. For most IL10 SNPs, it was noticeable that the orientation of the risk alleles is in agreement between the SLSJ and SAGE studies and in the opposite direction for CAPPS. No SNP in the IL10 gene was significantly associated with asthma or atopy in the BHS. Taken together, significant associations in the IL10 gene were observed in three studies. However, different SNPs were associated in different populations and the direction of the risk allele in the CAPPS study was reversed compared with the SLSJ and SAGE studies.
###end p 48
###begin p 49
Single SNP association results for asthma and atopy in the replication samples.
###end p 49
###begin p 50
CAPPS, Canadian Asthma Primary Prevention Study; SAGE, Study of Asthma Genes and the Environment; BHS, Busselton Health Study; AF, allele frequency; Fa, Number of informative families to conduct the test.
###end p 50
###begin p 51
P values below 0.05 are shown in bold. SNPs that are significant in the SLSJ study (Table 2) are underlined as well as the allele that increases the risk in that study. Coding non-synonymous SNPs are shown in bold.
###end p 51
###begin p 52
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1 </italic>
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 340 346 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1</italic>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86</italic>
###xml 748 750 748 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1097 1102 1097 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 1212 1220 1212 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
The associations observed for the IL1RL1 and CYP2R1 genes in the SLSJ study were not validated in the replication samples (Table 3). No other SNP in the IL1RL1 gene was associated with asthma or atopy in the replication studies except a non-synonymous coding SNP (rs1041973, Glu78Ala) that was borderline significant for atopy in SAGE. For CYP2R1, two additional SNPs located in the promoter and intron 1 were associated with asthma in the BHS. However, none of these SNPs were replicated in the other studies. For CD86, the promoter SNP (rs2715267) that was associated with atopy in the SLSJ (p = 0.004) could not be assessed in the other studies due to failure of the genotyping assay. However, two other intronic SNPs (rs9831894 and rs2332096, r2 = 0.48 in the European HapMap data), not in LD with rs2715267, were significantly associated with asthma in CAPPS. A different SNP (rs9282641) located in non-coding exon 1 was significantly associated with asthma in the BHS. This latter SNP was not in LD with any of the three SNPs associated with asthma in CAPPS and SLSJ. Accordingly, different CD86 polymorphims were associated with asthma in three populations. Finally, significant SNPs were observed in the CYP24A1 gene in all studies. However, there was no consistency with the SLSJ study in terms of phenotype and orientation of the risk alleles.
###end p 52
###begin p 53
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 497 500 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5a</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S8">8</xref>
The two-gene models were also performed in the replication samples for the five genes that were genotyped in CAMP, SAGE and BHS. The significant two-gene models involving IL10 and VDR as well as IL10 and IL1RL1 observed in the SLSJ study is not replicated in the CAPPS, SAGE and BHS. It should be noted that the sample sizes in the SAGE and CAPPS studies limit our ability to replicate the findings. For example, the number of cases contributing to the two-gene model involving IL10-rs1800896 and VDR-rs1544410 (Figure 5a) was approximately halved in SAGE and reduced to a quarter in CAPPS compared with the SLSJ study. However, even with similar power, the significant two-gene models observed in the SLSJ are not replicated in the BHS (see Additional file 8). Taken together, none of the significant two-gene models observed in the SLSJ study were properly replicated in CAPPS, SAGE and BHS.
###end p 53
###begin p 54
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 440 443 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 543 545 543 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 734 738 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 900 904 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 985 986 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
The significant two-gene models involving IL10 and VDR were also tested in the CAMP study. A different panel of SNPs was genotyped in CAMP and some of the two-gene models are significant (p < 0.05). The most significant two-gene models is observed between VDR-rs7975232 and IL10-rs1800896 (Wald test p = 0.018) or IL10-rs1800872 (Wald-test p = 0.016). Figure 6 shows the comparison of two-gene models observed in the SLSJ and CAMP studies. VDR-rs1544410 is not genotyped in CAMP, but rs7975232 was in moderately high LD with it (D' = 1.0 and r2 = 0.59, based on the HapMap CEU genotyping dataset). The gene-gene interaction models were similar between the two studies. The effect of the IL10 variant on asthma seemed dependent on the VDR variant. This can be appreciated in Figure 6 by comparing the solid, dotted and dashed lines between studies. The flip-flop phenomenon previously observed in the VDR gene between the SLSJ and CAMP studies [21,22] can also be appreciated in Figure 6 (the solid line is at the top in the SLSJ study and at the bottom in the CAMP study).
###end p 54
###begin p 55
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Two-gene models on asthma involving the <italic>IL10 </italic>and <italic>VDR </italic>genes in the SLSJ and the CAMP studies</bold>
###xml 248 250 248 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 536 538 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 650 653 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 729 732 729 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
Two-gene models on asthma involving the IL10 and VDR genes in the SLSJ and the CAMP studies. With two bi-allelic SNPs (3 genotypes per SNP), a 3 by 3 odds ratio matrix is calculated and visually represented. The y-axis shows the odds ratio on a log2 scale, which makes the odds ratio above and below 1 on the same visual scale. The IL10 genotypes are illustrated on the x-axis. Different panels of SNPs were genotyped between the two studies and the comparison for the VDR gene is made with different SNPs that are in LD (D' = 1.0 and r2 = 0.59, based on the HapMap CEU genotyping dataset). In the SLSJ study, the risks are evaluated relative to the VDR-GG and IL10-TT genotypes. In CAMP, the risks are evaluated relative to the VDR-CC and IL10-TT genotypes.
###end p 55
###begin title 56
Combined analyses
###end title 56
###begin p 57
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S9">9</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S10">10</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S11">11</xref>
Single SNP association tests and two-gene models were tested in the combined dataset. Overall, none of the SNPs are significantly associated with asthma or atopy after corrections for multiple testing (see Additional file 9). Similarly, the two-gene models for asthma and atopy were not significant (see Additional files 10 and 11, respectively).
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1</italic>
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1 </italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86</italic>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 625 633 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 997 1002 997 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1006 1010 1006 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
We performed a genetic association study between asthma and genes involved in the vitamin D pathway. SNPs located in five genes, including IL10, CYP24A1, IL1RL1, CYP2R1 and CD86, showed modest association with asthma or atopy in an asthma family study derived from the Saguenay_Lac-Saint-Jean population. Exploring gene-gene interactions in this pathway revealed significant two-gene models that refined risk evaluation for asthma. In an attempt to replicate these findings, we evaluated the significant genes in two additional Canadian studies and one Australian study. Again modest associations were observed for the IL10, CYP24A1 and CD86 genes for asthma or atopy. In general, SNPs showing association were different between studies or the orientation of the risk allele was reversed. Similarly, the significant two-gene models found in the original study were not replicated in the two additional Canadian studies and the Australian study. However, a significant two-gene model involving the IL10 and VDR gene was replicated in the American study.
###end p 59
###begin p 60
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 288 295 <span type="species:ncbi:9606">patient</span>
Overall, no genes or gene-gene interactions in the vitamin D pathway were consistently associated with asthma or atopy across all populations. This can be explained by multiple factors as discussed previously [3,42]. Briefly, asthma was defined differently between populations, including patient self-reported, physician's diagnosis, or a combination of clinical characteristics and objective threshold from methacholine challenges. In addition, the individual studies are either early or late-onset asthma. More specific for the current study, many environmental factors such as sun exposure and dietary vitamin D intake may differ between studies and explained some of the controversies and flip-flop observations. Considering the differences among populations, our replication effort may be more properly labeled as a descriptive study.
###end p 60
###begin p 61
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 1089 1094 1089 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1308 1309 1308 1309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1346 1348 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 1404 1406 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
A number of SNPs in the IL10 gene surrounding the promoter region and extending up to intron 1 were significantly associated with asthma in the SLSJ collection. All these SNPs were in tight LD and most of the genetic diversity at this locus was captured by only two haplotypes. Based on functional studies [45-50], the three-SNP promoter haplotypes formed by rs180096, rs1800871, and rs1800872 have been referred as the high and low IL10-producing haplotypes. IL10 is known as an anti-inflammatory cytokine [51]. Accordingly, it makes biological sense that a low IL10-producing haplotype would be associated with asthma, which is consistent with most of the literature [39,52-54]. Surprisingly, none of the promoter polymorphisms in IL10 were associated with asthma or atopy in the SAGE and CAPPS populations with the exception of rs1800896, which was associated with asthma in CAPPS. However, the orientation of the risk allele was reversed compared to what was observed in the SLSJ study and the vast majority of the scientific literature. In contrast, SNPs located in the 3' end of the IL10 gene (rs3024498 and rs3024492) were associated with asthma in the replicate samples. The functional consequences of these SNPs are unknown but they were previously associated with serum levels of calcidiol (25-OH-D3), the prehormone form of vitamin D [55], and with longitudinal decline rate of lung function [56].
###end p 61
###begin p 62
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 240 242 240 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</italic>
###xml 244 251 244 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1 </italic>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 426 427 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 458 459 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 460 461 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 506 514 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 612 620 608 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
###xml 796 803 792 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP2R1 </italic>
###xml 986 991 982 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 995 1000 991 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD28 </italic>
###xml 1055 1060 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD28 </italic>
###xml 1064 1069 1060 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 1201 1203 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1244 1249 1240 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 1361 1366 1357 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 1474 1479 1470 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD86 </italic>
###xml 1625 1630 1621 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD28 </italic>
###xml 1721 1723 1717 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1724 1726 1720 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1746 1753 1742 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 1881 1883 1877 1879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 1884 1886 1880 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 1934 1936 1930 1932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 1993 2000 1989 1996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 2116 2118 2112 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 2273 2275 2269 2271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 2494 2496 2490 2492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 2735 2737 2729 2731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 2896 2899 2890 2893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC </italic>
###xml 2903 2907 2897 2901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL8 </italic>
###xml 2914 2916 2908 2910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 2917 2919 2911 2913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 2920 2922 2914 2916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 2106 2114 <span type="species:ncbi:9606">patients</span>
Other genes in the vitamin D pathway tested in the current study have been previously associated with asthma or asthma-related phenotypes. In the German Asthma Family Study, Wjst et al. [55] identified SNPs in the IL10 gene but also in the GC, CYP2R1 and CYP24A1 genes that were significantly associated with asthma or IgE levels. Interestingly, SNPs in these genes were also associated with serum levels of calcidiol (25-OH-D3) and calcitriol [1alpha,25(OH)2D3]. In the SLSJ population, three SNPs in the CYP24A1 gene showed modest evidence of association with asthma or atopy (p < 0.05). In addition, the only CYP24A1 SNP (rs2248359) genotyped in common between the German and SLSJ population showed a consistent result with an increase risk of asthma associated with the C allele. SNPs in the CYP2R1 gene, encoding an enzyme implicated in earlier steps of the vitamin D metabolic pathway, were also associated with asthma in both the German and the SLSJ studies. Only one SNP in the CD86 and CD28 genes reached significance in the SLSJ population. The CD28 and CD86 interaction represents an important costimulatory signaling pathway for CD4 positive T cell activation and Th2 cytokine production [57]. The association between atopy and the CD86 promoter polymorphism rs2715267 was relatively strong in the SLSJ collection (p = 0.004). Different SNPs in the CD86 gene were also associated with asthma in the CAPPS and BHS studies. Thus, evidence is building to implicate CD86 as a susceptibility gene for asthma, but independent replications in larger population samples are required. In contrast, the overall results for CD28 are more consistent with the previous studies showing the lack of association with asthma [58-60]. Many SNPs in the IL1RL1 gene were associated with asthma in the SLSJ study. This receptor is required for the development of an effective Th2 response [61,62] and mediates the biological effects of IL-33 [63]. A functional promoter polymorphism (rs6543116) in the IL1RL1 gene was previously associated with atopic dermatitis and high total IgE levels in the sera from the same patients [64]. More recently, a genome-wide association scan for blood eosinophil count identified a strong association with an intronic SNP (rs1420101) in this gene [65]. The same SNP was then associated with asthma in a collection of ten different populations (7,996 cases and 44,890 controls). This SNP was not genotyped in the current study, but rs950880 can be used as a surrogate (r2 = 0.96 based on the European HapMap data). rs950880 was not associated with asthma or atopy in any of the four populations evaluated in the current study. However, a trend (p </= 0.10) in the same direction as the eosinophil/asthma study [65] was observed for asthma and atopy in the SLSJ study as well as for atopy in the BHS. Finally, the SLSJ results do not support previous observations with the GC and IL8 genes [55,66,67].
###end p 62
###begin p 63
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S12">12</xref>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 938 939 938 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 948 952 948 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1271 1276 1271 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 1522 1526 1522 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10</italic>
###xml 1541 1544 1541 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR</italic>
###xml 1603 1605 1603 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5b</xref>
###xml 1820 1824 1820 1824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 1918 1923 1918 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 2053 2058 2053 2058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 2062 2069 2062 2069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RL1 </italic>
###xml 2077 2079 2077 2079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5d</xref>
###xml 2114 2116 2114 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5e</xref>
###xml 2277 2282 2277 2282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 2286 2290 2286 2290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
It is reasonable to expect interactions among functionally related genes. In the SLSJ study, some two-gene models were more efficient at evaluating the risk of asthma compared with single SNP models. The models implicating functional variants in the VDR and IL10 genes are particularly interesting. We previously demonstrated that genetic variants in the VDR gene are associated with asthma [21]. Since the latter publication [21], we have genotyped more SNPs in the VDR gene in the same population and many SNPs between intron 2 and exon 9 are associated with asthma (see Additional file 12). The mechanism explaining this association is still unclear, but allele-specific expression at this locus implicates the presence of genetic variants that influence VDR expression [68]. In fact, we observed that the highly expressed haplotype was overtransmitted to asthmatic individuals, while the low expressed haplotype was undertransmitted [3]. These VDR haplotypes can be tagged by the SNP rs1544410 with the G allele being associated with the high-risk/high-expressed haplotype and the A allele being associated with the low-risk/low-expressed haplotype. As mentioned above, the low IL10-producing haplotype was associated with asthma in the same population (SLSJ). These IL10 haplotypes can be tagged by the SNP rs1800871 with the T allele being associated with the high-risk/low-producing haplotype and the C allele being associated with the low-risk/high-production haplotype. By combining the information of both SNPs (IL10-rs1800871 and VDR-rs1544410) we obtained the two-gene model shown in Figure 5b and that was a significant (p = 0.00018) predictor of the risk of asthma. In this model, the risk of asthma increased additively with the number of G alleles (tagging the high-risk/high-expressed haplotype) at the VDR locus and with the number of T alleles (tagging the high-risk/low-producing haplotype) at the IL10 locus. Similarly, other intriguing interactions between plausible candidate genes were observed in the SLSJ population, including IL10 and IL1RL1 (Figure 5d) as well as IL10 and CD86 (Figure 5e). Although interesting, the large majority of these two-gene models were not replicated in the other populations. In the CAMP study, a two gene-model involving IL10 and VDR variants mirrored the observation made in the SLSJ sample. However, further work will be required to demonstrate the relevance of these two-gene models in asthma.
###end p 63
###begin p 64
###xml 81 82 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 83 85 79 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 157 158 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 327 328 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 329 330 321 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 398 402 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VDR </italic>
###xml 516 517 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 518 520 506 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 678 679 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 680 681 664 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 892 893 872 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 894 896 874 876 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 897 899 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1002 1003 978 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1004 1006 980 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sub>
###xml 1031 1033 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 1034 1036 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 1524 1526 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
The cascade of enzymatic reactions that lead to the biosynthesis of 1alpha,25(OH)2D3 is complex and requires the participation of many gene products (Figure 1). It is conceivable that polymorphisms in any of several genes in this pathway could lead to differences in endogenous biosynthesis and bioavailability of 1alpha,25(OH)2D3. At a more downstream step in the pathway, genetic variants in the VDR itself or in genes implicated in the transcriptional machinery, can influence the sensitivity of the 1alpha,25(OH)2D3 stimulus. Further downstream are transcriptionally regulated genes, or vitamin responsive genes, that mediate the broad physiological actions of 1alpha,25(OH)2D3. Again, polymorphisms in these genes are prime candidates to influence the vitamin D response. However, at this level the task is rather challenging owing to the large number of genes regulated by 1alpha,25(OH)2D3 [14]. An extra layer of complexity exists, knowing that the regulation of gene expression by 1alpha,25(OH)2D3 is highly cell-specific [69,70]. Accordingly, a large number of genes can determine the overall response to the vitamin D pathway. With this in perspective, gene selection in the current study was not comprehensive. On the other hand, the results of the current study may have implications in a wider scope than the field of asthma and asthma-related phenotypes. SNPs associated with asthma in the vitamin D pathway genes may influence the overall vitamin D sensitivity and consequently influence many other diseases [55].
###end p 64
###begin title 65
Conclusion
###end title 65
###begin p 66
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL10 </italic>
###xml 530 538 530 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP24A1 </italic>
Cumulative observations implicate the vitamin D pathway in immune responses. By studying genes involved in this pathway, we identified genetic polymorphisms modestly associated with asthma and atopy in asthmatic families from the Saguenay_Lac-Saint-Jean region. Significant two-gene models that include interactions between components of the pathway were also identified. We then attempted to replicate the findings in two additional Canadian studies and one Australian study. Similar to the SLSJ study, some SNPs in the IL10 and CYP24A1 genes were modestly associated with asthma or atopy. However, the SNPs or the orientation of the risk alleles were different between populations. It is conceivable that the effect of the VDR system in immune responses can be overruled by more potent immune pathways. Accordingly, the effect of the vitamin D pathway might be detectable only in specific environments or age-related contexts. Further studies are warranted to confirm the single SNP and the multilocus models associated with asthma in the current study.
###end p 66
###begin title 67
List of abbreviations used
###end title 67
###begin p 68
###xml 461 462 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 741 742 741 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 839 840 839 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
BHS: Busselton Health Study; CAMP: Childhood Asthma Management Program; CAPPS: Canadian Asthma Primary Prevention Study; CD28: CD28 molecule; CD86: CD86 molecule; CYP24A1: cytochrome P450, family 24, subfamily A, polypeptide 1; CYP27A1: cytochrome P450, family 27, subfamily A, polypeptide 1; CYP27B1: cytochrome P450, family 27, subfamily B, polypeptide 1; CYP2R1: cytochrome P450, family 2, subfamily R, polypeptide 1; FBAT: family based association test; FEV1: forced expiratory volume in 1 second; GC: vitamin D binding protein; IL10: interleukin 10; IL1RL1: interleukin 1 receptor-like 1; IL8: interleukin 8; LD: linkage disequilibrium; NHS: Nurses' Health Study; PC20: the concentration of methacholine that causes a 20% decline in FEV1; SAGE: Study of Asthma Genes and the Environment; SKIIP: SKI interacting protein; SLSJ: Saguenay_Lac-Saint-Jean; SNP: single-nucleotide-polymorphism; VDR: vitamin D receptor.
###end p 68
###begin title 69
Competing interests
###end title 69
###begin p 70
The authors declare that they have no competing interests.
###end p 70
###begin title 71
Authors' contributions
###end title 71
###begin p 72
YB carried out gene/SNP selection, genotyping in the SLSJ study, integration of datasets and was primary author of the manuscript. ML performed statistical analyses in SLSJ, SAGE, CAPPS, and BHS. AHP carried out statistical analyses in CAMP. DD, JQH and AS provided statistical, genotyping and genetics expertise to replicate the findings in the AllerGen study samples. JHW made substantial intellectual contribution in gene selection. ALJ, AWM and LJP participated in the conception and coordination of the BHS. BAR and STW participated in the conception and coordination of CAMP. ALK participated in the coordination of the SAGE study. AB conceived and acquired funding for the SAGE and CAPPS studies. TJH and CL conceived and acquired funding for the SLSJ study. TJH also provided general supervision of the research group. All authors read and approved the final manuscript.
###end p 72
###begin title 73
Supplementary Material
###end title 73
###begin title 74
Additional file 1
###end title 74
###begin p 75
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNP characteristics</bold>
SNP characteristics. Table showing the SNPs selected for genotyping and their characteristics including chromosomal location, type of variation, minor allele, minor allele frequency, and Hardy-Weinberg p value.
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Additional file 2
###end title 77
###begin p 78
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genetic association of SNPs in the vitamin D pathway genes with asthma and atopy in the SLSJ study</bold>
###xml 663 666 663 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10 </sub>
###xml 587 592 <span type="species:ncbi:9606">Human</span>
Genetic association of SNPs in the vitamin D pathway genes with asthma and atopy in the SLSJ study. Each subfigure presents the result of one gene. The top line indicates the gene name and symbol. The upper part of each subfigure shows the exon-intron structure of the gene and the localization of the genotyped SNPs. The coding exons are shown in black and the untranslated regions are shown in grey. The lower part of each subfigure illustrates the association results for asthma (solid circles) and atopy (open circles). The x-axis shows the localization of the gene and SNPs on NCBI Human Genome build 35. The y-axis shows the FBAT empirical p values on a log10 scale. The lower and upper dashed lines represent p value thresholds of 0.05 and 0.001, respectively. The upper and lower parts of each subfigure are shown on the same scale.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Additional file 3
###end title 80
###begin p 81
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The overall distribution of p values derived from single marker FBAT association tests in the SLSJ study</bold>
The overall distribution of p values derived from single marker FBAT association tests in the SLSJ study. The top panels are Q-Q plots showing the distribution of observed p values against the expected distribution for asthma and atopy. The bottom panels are histograms showing the distribution of p values for asthma and atopy. The dashed lines represent the mean number of p values that is expected by chance. Association test results for 83 SNPs located in 11 genes are illustrated.
###end p 81
###begin p 82
Click here for file
###end p 82
###begin title 83
Additional file 4
###end title 83
###begin p 84
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Single SNP association results for asthma and atopy in the Saguenay<sup>_</sup>Lac-Saint-Jean study</bold>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">_</sup>
Single SNP association results for asthma and atopy in the Saguenay_Lac-Saint-Jean study. Table showing the FBAT results for all SNPs in the Saguenay_Lac-Saint-Jean study.
###end p 84
###begin p 85
Click here for file
###end p 85
###begin title 86
Additional file 5
###end title 86
###begin p 87
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Linkage disequilibrium (LD) plots surrounding eleven genes involved in the vitamin D pathway in the SLSJ study</bold>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 424 426 424 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 476 478 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 489 491 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
Linkage disequilibrium (LD) plots surrounding eleven genes involved in the vitamin D pathway in the SLSJ study. The LD plots were generated by Haploview 3.32 [41]. Gene symbols are indicated at the top of each graph. The top horizontal bar illustrates the location of SNPs on a physical scale. The color of squares illustrates the strength of pairwise r2 values on a black and white scale where black indicates perfect LD (r2 = 1.00) and white indicates perfect equilibrium (r2 = 0). The r2 LD value is also indicated within each square. Blocks are defined using the Gabriel et al [71] definition. Failed and monomorphic SNPs as well as SNPs not in Hardy-Weinberg equilibrium are not illustrated.
###end p 87
###begin p 88
Click here for file
###end p 88
###begin title 89
Additional file 6
###end title 89
###begin p 90
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Two-gene model analyses on atopy in the SLSJ study</bold>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
Two-gene model analyses on atopy in the SLSJ study. Visual representation of results is explained in Figure 4.
###end p 90
###begin p 91
Click here for file
###end p 91
###begin title 92
Additional file 7
###end title 92
###begin p 93
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Single SNP association results for asthma and atopy in the replication samples</bold>
Single SNP association results for asthma and atopy in the replication samples. Table showing the results for all SNPs in the replication samples.
###end p 93
###begin p 94
Click here for file
###end p 94
###begin title 95
Additional file 8
###end title 95
###begin p 96
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Two-gene model analyses on asthma in the BHS</bold>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
Two-gene model analyses on asthma in the BHS. Visual representation of results is explained in Figure 4.
###end p 96
###begin p 97
Click here for file
###end p 97
###begin title 98
Additional file 9
###end title 98
###begin p 99
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Single SNP association results for asthma and atopy in combined analyses (SLSJ, CAPPS, SAGE, and BHS)</bold>
Single SNP association results for asthma and atopy in combined analyses (SLSJ, CAPPS, SAGE, and BHS). Table showing the results for the combined analyses.
###end p 99
###begin p 100
Click here for file
###end p 100
###begin title 101
Additional file 10
###end title 101
###begin p 102
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Two-gene model analyses on asthma in the combined dataset for genes involved in the vitamin D pathway</bold>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
Two-gene model analyses on asthma in the combined dataset for genes involved in the vitamin D pathway. Visual representation of results is explained in Figure 4.
###end p 102
###begin p 103
Click here for file
###end p 103
###begin title 104
Additional file 11
###end title 104
###begin p 105
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Two-gene model analyses on atopy in the combined dataset for genes involved in the vitamin D pathway</bold>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
Two-gene model analyses on atopy in the combined dataset for genes involved in the vitamin D pathway. Visual representation of results is explained in Figure 4.
###end p 105
###begin p 106
Click here for file
###end p 106
###begin title 107
Additional file 12
###end title 107
###begin p 108
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genetic association between SNPs in the vitamin D receptor gene and asthma in the SLSJ study</bold>
###xml 511 514 511 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10 </sub>
###xml 435 440 <span type="species:ncbi:9606">Human</span>
Genetic association between SNPs in the vitamin D receptor gene and asthma in the SLSJ study. The upper part of the figure shows the exon-intron structure of the gene and the localization of the genotyped SNPs. The coding exons are shown in black and the untranslated regions are shown in grey. The lower part of the figure illustrates the association results for asthma. The x-axis shows the localization of the gene and SNPs on NCBI Human Genome build 35. The y-axis shows the FBAT empirical p values on a log10 scale. The lower and upper dashed lines represent p value thresholds of 0.05 and 0.001, respectively. The upper and lower parts of the figure are shown on the same scale.
###end p 108
###begin p 109
Click here for file
###end p 109
###begin title 110
Acknowledgements
###end title 110
###begin p 111
###xml 1778 1783 <span type="species:ncbi:9606">Women</span>
###xml 1831 1836 <span type="species:ncbi:9606">human</span>
###xml 2453 2465 <span type="species:ncbi:9606">participants</span>
We gratefully acknowledge Peter D Pare for in-depth review of the manuscript. Y. Bosse was the recipient of a fellowship award from the Canadian Institutes of Health and Research (CIHR) and is currently a research scholar from the Heart and Stroke Foundation of Canada. A.H. Poon is recipient of a fellowship award from the Croucher Foundation. D. Daley was the recipient of a fellowship award from the CIHR and is currently holding a Canada Research Chair on the Genetic Epidemiology of Complex Diseases and a Michael Smith Career Scholar Award. A. Sandford is the recipient of a Canada Research Chair in genetics. J.H. White is supported by a National Scientist Award from the "Fonds de la Recherche en Sante du Quebec" (FRSQ). B.A. Raby is a recipient of a Mentored Clinical Scientist Development Award from NIH/NHLBI (K08 HL074193). T.J. Hudson is currently funded by a Senior Investigator Award of the Ontario Institute for Cancer Research and was the recipient of a Clinician-Scientist Award in Translational Research by the Burroughs Wellcome Fund and an Investigator Award from the Canadian Institutes of Health Research. C. Laprise is the chairholder of the Canada Research Chair on genetic determinants in asthma and the director of the Inflammation and Remodeling Strategic Group of the Respiratory Health Network of the FRSQ, which partially support the French Canadian study. Additional support for this study came from the Networks of Centres of Excellence, Allergy, Genes and Environment Network (AllerGen). We acknowledge the CAMP investigators and research team, supported by NHLBI, for collection of CAMP Genetic Ancillary Study data. All work on data collected from the CAMP Genetic Ancillary Study was conducted at the Channing Laboratory of the Brigham and Women's Hospital under appropriate CAMP policies and human subject's protections. The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, and T32 HL07427 from the National Heart, Lung and Blood Institute, National Institutes of Health. Additional support for this research came from AllerGen. A. Becker, Y. Bosse, D. Daley, J.-Q. He, T.J. Hudson, A.L. James, A.L. Kozyrskyj, C. Laprise, M. Lemire, A.W. Musk, L.J. Palmer, P.D. Pare and A. Sandford are members of AllerGen. The Busselton Health Study received support from Healthway, Western Australia for the 1994 re-survey. The Busselton Health Study acknowledges the study participants and local voluntary survey staff.
###end p 111
###begin article-title 112
National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002
###end article-title 112
###begin article-title 113
Genetics of asthma: a review
###end article-title 113
###begin article-title 114
Toward a comprehensive set of asthma susceptibility genes
###end article-title 114
###begin article-title 115
Asthma genetics the long and winding road to gene discovery
###end article-title 115
###begin article-title 116
Recent advances in asthma genetics
###end article-title 116
###begin article-title 117
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
###end article-title 117
###begin article-title 118
Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function
###end article-title 118
###begin article-title 119
Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus
###end article-title 119
###begin article-title 120
###xml 54 59 <span type="species:ncbi:9606">human</span>
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
###end article-title 120
###begin article-title 121
Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system
###end article-title 121
###begin article-title 122
The immunological functions of the vitamin D endocrine system
###end article-title 122
###begin article-title 123
Vitamin D signaling, infectious diseases, and regulation of innate immunity
###end article-title 123
###begin article-title 124
Vitamin D
###end article-title 124
###begin article-title 125
Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes
###end article-title 125
###begin article-title 126
###xml 64 69 <span type="species:ncbi:9606">human</span>
Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells
###end article-title 126
###begin article-title 127
Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system
###end article-title 127
###begin article-title 128
Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene
###end article-title 128
###begin article-title 129
###xml 104 108 <span type="species:ncbi:10090">mice</span>
1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543)
###end article-title 129
###begin article-title 130
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Vitamin D receptor-deficient mice fail to develop experimental allergic asthma
###end article-title 130
###begin article-title 131
The vitamin D receptor gene FokI polymorphism: functional impact on the immune system
###end article-title 131
###begin article-title 132
Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy
###end article-title 132
###begin article-title 133
Association of vitamin D receptor gene polymorphisms with childhood and adult asthma
###end article-title 133
###begin article-title 134
A testing framework for identifying susceptibility genes in the presence of epistasis
###end article-title 134
###begin article-title 135
###xml 58 63 <span type="species:ncbi:9606">human</span>
Nonparametric tests of association of multiple genes with human disease
###end article-title 135
###begin article-title 136
Skin tests used in type I allergy testing Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology
###end article-title 136
###begin article-title 137
Association of urokinase-type plasminogen activator with asthma and atopy
###end article-title 137
###begin article-title 138
###xml 139 146 <span type="species:ncbi:9606">infants</span>
A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants
###end article-title 138
###begin article-title 139
The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age
###end article-title 139
###begin article-title 140
The Childhood Asthma Management Program (CAMP) design, rationale, and methods. Childhood Asthma Management Program Research Group
###end article-title 140
###begin article-title 141
###xml 49 57 <span type="species:ncbi:9606">children</span>
Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group
###end article-title 141
###begin article-title 142
The pleiotropic actions of vitamin D
###end article-title 142
###begin article-title 143
Enzymes involved in the activation and inactivation of vitamin D
###end article-title 143
###begin article-title 144
Emerging insights into the coactivator role of NCoA62/SKIP in Vitamin D-mediated transcription
###end article-title 144
###begin article-title 145
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 145
###begin article-title 146
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium
###end article-title 146
###begin article-title 147
SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery
###end article-title 147
###begin article-title 148
FastPCR: a PCR primer design and repeat sequence searching software with additional tools for the manipulation and analysis of DNA and protein
###end article-title 148
###begin article-title 149
BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping
###end article-title 149
###begin article-title 150
###xml 65 73 <span type="species:ncbi:9606">children</span>
IL10 gene polymorphisms are associated with asthma phenotypes in children
###end article-title 150
###begin article-title 151
Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics
###end article-title 151
###begin article-title 152
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 152
###begin article-title 153
Analyses of associations with asthma in four asthma population samples from Canada and Australia
###end article-title 153
###begin article-title 154
Case/pseudocontrol analysis in genetic association studies: A unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects
###end article-title 154
###begin article-title 155
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data
###end article-title 155
###begin article-title 156
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10
###end article-title 156
###begin article-title 157
Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis
###end article-title 157
###begin article-title 158
Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10)
###end article-title 158
###begin article-title 159
IL-10 gene promoter polymorphisms in rheumatoid arthritis
###end article-title 159
###begin article-title 160
An investigation of polymorphism in the interleukin-10 gene promoter
###end article-title 160
###begin article-title 161
[Correlation between polymorphism of IL-4 and IL-10 gene promoter and childhood asthma and their impact upon cytokine expression]
###end article-title 161
###begin article-title 162
Interleukin-10 and the interleukin-10 receptor
###end article-title 162
###begin article-title 163
Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma
###end article-title 163
###begin article-title 164
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Haplotype associated with low interleukin-10 production in patients with severe asthma
###end article-title 164
###begin article-title 165
Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma
###end article-title 165
###begin article-title 166
Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway
###end article-title 166
###begin article-title 167
Longitudinal decline in lung function: evaluation of interleukin-10 genetic polymorphisms in firefighters
###end article-title 167
###begin article-title 168
Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression
###end article-title 168
###begin article-title 169
Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy
###end article-title 169
###begin article-title 170
Fine mapping of an IgE-controlling gene on chromosome 2q: Analysis of CTLA4 and CD28
###end article-title 170
###begin article-title 171
Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese population
###end article-title 171
###begin article-title 172
###xml 38 44 <span type="species:ncbi:10090">murine</span>
T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function
###end article-title 172
###begin article-title 173
T1/ST2--an IL-1 receptor-like modulator of immune responses
###end article-title 173
###begin article-title 174
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
###end article-title 174
###begin article-title 175
Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis
###end article-title 175
###begin article-title 176
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction
###end article-title 176
###begin article-title 177
Association of vitamin D binding protein variants with chronic mucus hypersecretion in Iceland
###end article-title 177
###begin article-title 178
###xml 96 123 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis
###end article-title 178
###begin article-title 179
###xml 38 43 <span type="species:ncbi:9606">human</span>
Mapping common regulatory variants to human haplotypes
###end article-title 179
###begin article-title 180
1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes
###end article-title 180
###begin article-title 181
Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis
###end article-title 181
###begin article-title 182
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome
###end article-title 182

